Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Kitcheetahon Apr 05, 2018 5:39pm
129 Views
Post# 27839219

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:selling

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:sellingThose smoke breaks are about to get a lot more interesting

LaserStock29 wrote:
Smallcap84 wrote: Its been said here time and again that completeing ph1 in king and the current price of the stock and severe lack of any buying/speculating interest is reflecting that...We seem to be "stuck" again or as some would say "having a smoke break" in the trials as we have not treated anyone now for over apx 7 weeks since p6..I think the stock will jump sharply if we can just get the rest 7,8,9 treated because it seems right now that the market isn't expecting a conclusion for this trial any time soon..imo...


(roughly )

April 20th is 90 days for P5 

May 8th is 90 days for P6

AFAIK Phase 2 can be applied for after Phase 1 endpoints are satisfied.. which is the first cystoscope 3 months after P9 is treated.

So the questions

1. Imminant JV with a canna company?

2. P9 treatment date?       

Until then.. just enjoy the smoke break with Rudolph.




Bullboard Posts